V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Convergent action on AMR identified as an important area of intervention
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
Subscribe To Our Newsletter & Stay Updated
